Stēto

Stēto, founded in 2022 and headquartered in France, is poised to revolutionize diabetes care with its innovative Remote Patient Monitoring solutions. The company operates in the Health Care and Health and Wellness industries, addressing the urgent global need for adaptive diabetes management. With an alarming projection of 800 million people affected by diabetes by 2045, traditional healthcare models are proving inadequate.

The company's slogan, "Creating continuous care in diabetes", encapsulates its mission to transform diabetes treatment beyond periodic medical appointments. By leveraging digital tools, Stēto aims to deliver daily medical support, cultivating a proactive approach to diabetes management.

Recently, Stēto secured a €1.20M Seed Round investment on 10 November 2023, with backing from the reputable Bpifrance. This funding underscores investor confidence in Stēto's potential to lead significant advancements in diabetes care.